Pharma's Almanac: Nice Insight's Content Community

Optimized Residual dsRNA Detection for mRNA Therapeutics

A team of experts from Samsung Biologics discusses the company’s development of a superior ELISA-based method for dsRNA detection that ensures greater accuracy and reliability.

Advanced Therapies

Oct 25, 2024

A New Vision for Progressing Advanced Therapies

In this Q&A, ReciBioPharm’s Nathaniel Youndt discusses the company’s evolving strategy and how it is strategizing to become a leader in nucleic acid manufacturing and drive the future of advanced therapies.

Gene Editing

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Touchlight’s Elena Stoyanova, Ph.D., and Tom Adie, Ph.D., explain how the company’s new nonviral MegaBulb DNA (mbDNA) offers a high-purity, synthetic CRISPR ssDNA template that demonstrates remarkable efficiency and minimal toxicity.

QbD

Oct 29, 2024

Designing Quality into Biomanufacturing

Tanvex CDMO’s Michelle Kneeland and Miguel Carrion discuss how QbD’s comprehensive approach and clear objectives not only meet but can anticipate regulatory requirements, establishing a new standard in biopharmaceutical manufacturing that prioritizes quality at every step.

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

Cell Therapy

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

In this Q&A, OrganaBio’s Chief Executive Officer Justin Irizarry discusses the strategies and operational philosophies driving the company and how it plans to navigate future challenges and opportunities in the rapidly evolving cell therapy landscape.

News

Financing

Microbiologics Acquires SensID, Expanding Expertise in Diagnostic Quality Controls

Clinical Trials

Broad Clinical Labs

Clinical Trials

New SELECT trial analysis with semaglutide 2.4 mg showed a reduction in hospital admissions with heart disease and overweight

Clinical Trials

OncoResponse to Present Phase 1 Results of Clinical Study of OR502, anti-LILRB2 Antibody, as a Late-Breaker Poster

Biomanufacturing

Nov 04, 2024

Olon is Ready to Host Productions in the New Facility Dedicated to Ultra-Potent Compounds

Bioscience

Nov 04, 2024

Neurocrine Biosciences Presents Breadth of Data Over Time Following Treatment With INGREZZA Capsules

The Road to the Max: Australia

Top 5

dbDNA

Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA

Top 5

dbDNA

Aug 19, 2024

Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA

RoundTable

View all roundtable

RoundTable Topics

Evolving Technologies

How have evolving technologies like artificial intelligence (AI) and machine learning (ML) changed how you conduct research, manufacturing, or business?

Stephan Rosenberger, Ph.D.

David Vodak, Ph.D.

Wolfram Schulze

Alan Stevens, Ph.D.

Valerie Van Hulle

The increasing manufacturing complexity of new medicines and the desire to reduce “time to market” are driving faster development and implementation of AI solutions in our activities.

View all Answers

RoundTable

View all roundtable

Evolving Technologies

How have evolving technologies like artificial intelligence (AI) and machine learning (ML) changed how you conduct research, manufacturing, or business?

Stephan Rosenberger, Ph.D.

David Vodak, Ph.D.

Wolfram Schulze

Alan Stevens, Ph.D.

Valerie Van Hulle

The increasing manufacturing complexity of new medicines and the desire to reduce “time to market” are driving faster development and implementation of AI solutions in our activities.

View all Answers

RoundTable Topics

Evolving Technologies

Regulatory

Personalized and Precision Medicine

Therapeutic Areas

Post-COVID-19 Supply Chain

Challenges

Sustainability

INDUSTRIAL INNOVATION

Global Access

Social Media Marketing

Milestones

2021 Projections

Innovation

Investment Trends

Year in Review

U.S. Market

BIOSECURE

Digital Connections

Outsourcing Dynamics

Predictions

Virtual BD and Marketing

Dealing with a Crisis

Unmet medical needs

Lessons from the Pandemic

Leadership

Now Trending

Plan Ahead: Mastering Your AI Budget for 2025 Success

AI

Oct 07, 2024

Plan Ahead: Mastering Your AI Budget for 2025 Success

QbD

Oct 29, 2024

Designing Quality into Biomanufacturing

RNA

Optimized Residual dsRNA Detection for mRNA Therapeutics

Biopharma

Sep 27, 2024

Revolutionizing Autoimmune Disease Management with Soluble Bispecific Receptors

Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform

Exposomics

Sep 05, 2024

Transforming Precision Medicine through a High-Resolution Temporal Exposome Platform

BIOSECURE Act

Oct 28, 2024

Can you discuss the anticipated impacts of the BIOSECURE Act on the biopharmaceutical landscape?

Process Development

Sep 24, 2024

Economic Benefits of Digital Process Development

Bioassays

Developing a Toolbox of Functional Bioassays for Optimizing ADCC

Biotech

Sep 23, 2024

Five Small Biotechs to Watch: October 2024

Cell Therapy

Agile Cell Supply and Processing to Accelerate Development of the Medicines of the Future

Innovation

Oct 28, 2024

How is the pharmaceutical industry integrating innovations from adjacent industries to enhance drug development and production?

Transforming Drug Development through a Female Perspective

Female-Centric

Sep 10, 2024

Transforming Drug Development through a Female Perspective

Clinical Trials

Oct 29, 2024

Passion and Understanding Essential for Rare Disease Clinical Trials

Commercialization

Sep 17, 2024

Development Strategies for Overcoming Commercialization Challenges

Gene Editing

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Ophthalmology

Sep 16, 2024

The Shift from Early- to Late-Phase Ophthalmology Retina Market in 2024: Proactive Planning for Late-Stage Clinical Success

Videos

View all videos

Immuno-Oncology

May 24, 2022

Building Multiple Platforms to Address Difficult-to-Treat Cancers

On the Road to 50 States, Derek Hennecke, Investor at Inceptor Bio, talks to Nigel about what attracted him to Inceptor Bio and the technologies which Inceptor Bio are currently focusing on.

Immuno-Oncology

May 24, 2022

Building Multiple Platforms to Address Difficult-to-Treat Cancers

Stem Cell Therapy

Dec 12, 2023

Designing A Recipe for Stem Cell Therapy Success

Meet the Crew

Aug 07, 2024

Assembling the Crew

Decentralized Clinical Trials

Nov 17, 2022

The Evolving Role of Remote Monitoring

Transforming Market Insights into Growth

Marketing

May 09, 2022

Transforming Market Insights into Growth

The Power of Aqueous Detergents in Critical Cleaning

Aqueous Cleaning

Dec 05, 2023

The Power of Aqueous Detergents in Critical Cleaning

Supply Chain

Dec 12, 2023

Rethinking the Pharma/Biopharma Supply Chain to Maximize Resilience

Biologics CDMO

Jan 26, 2022

Growing as a Trusted, Dedicated Commercial Biologics CDMO

Preparing to Launch

Aug 07, 2024

Preparing the Yacht for the Race

Data Connectivity

Jan 19, 2022

Discussing the Advancements in Oncology

Failure to Launch

Aug 07, 2024

Disaster Strikes

Setting Sail

Aug 07, 2024

Sailing into the Trade Winds

In Focus

Viscosity Reduction

Aug 10, 2023

Viscosity Reduction with An Excipient Platform and Feasibility Testing Service

Robotic Sterile Fill-Finish

Feb 14, 2024

Reducing Time to First-in-Human Trials with Robotic Sterile Fill-Finish Manufacturing Services

Lyophilization

Oct 22, 2024

Pioneering Innovation in Pharmaceutical Lyophilization

Developability

Aug 26, 2024

Assessing Developability and Designing Advanceable Formulations from the Start

Commercialization

Sep 17, 2024

Development Strategies for Overcoming Commercialization Challenges

Transforming Pharmaceutical Packaging with Sustainable, Cutting-Edge Solutions

Sustainable Packaging

Jul 02, 2024

Transforming Pharmaceutical Packaging with Sustainable, Cutting-Edge Solutions

Latest

View all latest

Chemotherapy

Modernizing Dated Approaches to Oncology Care

Partnerships

University-Industry Partnerships Tackling Genetic Disease Therapies and Diagnostic Innovation

Diagnostics

Avicena Systems' Cutting-Edge Biopreparedness and Testing Platform

Antibodies

Reshaping the Approach to Therapeutic Development with i-Bodies

Clinical Trials

More Efficient and Cost-Effective Clinical Trials Down Under

Biosensors

The Partnerships Powering Next-Gen Oncology Care

CRISPR

The Groundbreaking Potential of CRISPR Gene Editing

Oncology

Academia CDMO Clinical CRO Drug Discovery Early R&D Excipients / Intermediates Financing Equipment Preclinical CRO Supply Chain Technology

Celebrating a Decade of Oncology Innovation at ONJ

Areas of Interests

A comprehensive market analysis with 110 major company profiles and detailed CDMO pricing information.

Over 60 company profiles covering the leading mRNA and LNP contract manufacturing organizations. Unique pricing comparison for the end-to-end manufacturing process.

Optimize your manufacturing process using 50+ established CDMO overviews and a requisite pricing study for small, mid sized and large manufacturers.

Comprehensive analysis of mammalian cell culture CDMOs including price benchmarking, market trends and over 80 company profiles.

Over 80 company profiles and analysis of leading microbial fermentation CDMO; exclusive market analysis and price comparison.

Understand the emerging ADC market with profiles on 30 notable CDMOs and an analysis of the value chain of mAbs, linkers and payloads. Benchmark with robust manufacturing pricing.

Exclusive pricing from 20+ CDMOs and market insight for pDNA as a reagent for advanced therapies and as a primary therapeutic.

Robust analysis of gene therapy market, includes 50 company profiles of AAV, Lentiviral and non-viral gene therapy CDMOs.

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.

Over 80 extensive CDMO profiles for an all-encompassing benchmarking report. Exclusive pricing comparison and updated global GMP regulatory landscape

Discover the cell therapy market with unique insights, analysis, and overviews of allogeneic and autologous cell therapy CDMOs.